{Reference Type}: Journal Article
{Title}: Semaphorin 3C and Its Receptors in Cancer and Cancer Stem-Like Cells.
{Author}: Hao J;Yu JS;
{Journal}: Biomedicines
{Volume}: 6
{Issue}: 2
{Year}: Apr 2018 8
{Factor}: 4.757
{DOI}: 10.3390/biomedicines6020042
{Abstract}: Neurodevelopmental programs are frequently dysregulated in cancer. Semaphorins are a large family of guidance cues that direct neuronal network formation and are also implicated in cancer. Semaphorins have two kinds of receptors, neuropilins and plexins. Besides their role in development, semaphorin signaling may promote or suppress tumors depending on their context. Sema3C is a secreted semaphorin that plays an important role in the maintenance of cancer stem-like cells, promotes migration and invasion, and may facilitate angiogenesis. Therapeutic strategies that inhibit Sema3C signaling may improve cancer control. This review will summarize the current research on the Sema3C pathway and its potential as a therapeutic target.